Phosphorylation of vasodilator-stimulated phosphoprotein (VASP) dampens hepatic ischemia-reperfusion injury.
Recent work has demonstrated that the formation of platelet neutrophil complexes (PNCs) affects inflammatory tissue injury. Vasodilator-stimulated phosphoprotein (VASP) is crucially involved into the control of PNC formation and myocardial reperfusion injury. Given the clinical importance of hepatic...
Main Authors: | David Köhler, Philipp Birk, Klemens König, Andreas Straub, Therese Eldh, Julio C Morote-Garcia, Peter Rosenberger |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3245274?pdf=render |
Similar Items
-
Deficiency of vasodilator-stimulated phosphoprotein (VASP) increases blood-brain-barrier damage and edema formation after ischemic stroke in mice.
by: Peter Kraft, et al.
Published: (2010-12-01) -
Phosphorylated vasodilator-stimulated phosphoprotein (P-VASPSer239) in platelets is increased by nitrite and partially deoxygenated erythrocytes.
by: Sirada Srihirun, et al.
Published: (2018-01-01) -
Oxidative stress impairs cGMP-dependent protein kinase activation and vasodilator-stimulated phosphoprotein serine-phosphorylation
by: Anees A. Banday, et al.
Published: (2019-01-01) -
The uncoordinated-5 homolog B receptor affects hepatic ischemia reperfusion injury.
by: Klemens König, et al.
Published: (2012-01-01) -
Role of VASP Phosphorylation Assay in Monitoring the Antiplatelet Therapy
by: Fedor Marian, et al.
Published: (2013-03-01)